top of page
Cluster News
Paris-Saclay Cancer Cluster and HEC Paris Join Forces to Accelerate Scientific Innovation and Entrepreneurship
The Paris-Saclay Cancer Cluster (PSCC) and HEC Paris have announced a strategic partnership that aims to foster a dynamic bridge between scientific excellence and entrepreneurial ambition. By combining the deep-tech innovation ecosystem of the PSCC with HEC Paris Innovation & Entrepreneurship Institute’s renowned expertise in business acceleration, the collaboration aspires to fast-track the journey from groundbreaking research to real-world impact. Located at the heart of on
Jun 23, 2025
8 new projects to be supported by the PSCC
We are thrilled to announce that 5 new projects have been selected by the PSCC to benefit from its support: Carla Biotherapeutics : A...
Jun 23, 2025
La Fondation ARC et le Paris-Saclay Cancer Cluster unissent leurs forces pour accélérer l’innovation en cancérologie (french)
La Fondation ARC pour la recherche sur le cancer et le Paris-Saclay Cancer Cluster (PSCC) annoncent la signature d’un partenariat stratégique visant à renforcer les passerelles entre recherche académique et développement thérapeutique avec un objectif commun : accélérer le développement de solutions innovantes concrètes au bénéfice des patients atteints de cancer. Face à la complexité des défis posés par le cancer, tant sur le plan biologique que médical, sociétal et économiq
Jun 19, 2025
Oncology meets digital health: The PSCC and Future4Care join forces to accelerate innovation
The Paris-Saclay Cancer Cluster (PSCC) and Future4Care have announced a strategic partnership to accelerate innovation in healthcare. This collaboration aims to enhance support for start-ups working at the crossroads of oncology and digital health by leveraging the strengths and networks of complementary ecosystems. As the need for transformative healthcare solutions continues to grow, the PSCC remains committed to translating world-class academic research into innovative the
Jun 19, 2025
Cluster News
Paris-Saclay Cancer Cluster announces the 10 BOOST Grant laureates
Grants ranging from €120,000 to €250,000 to help 10 high-potential oncology start-ups advance towards critical value-creating milestones • Against a backdrop of tougher funding conditions for innovative companies, the PSCC is strengthening its role as an operational accelerator • The BOOST Grant is designed to fund the critical milestones that determine access to investors, industry partners, the clinic or the market • The laureates’ projects span the full onco
Jun 2
In Villejuif, the Paris-Saclay Cancer Cluster deploys an operational model to accelerate innovation in oncology
Villejuif, February 4, 2026 - On World Cancer Day , the Paris-Saclay Cancer Cluster (PSCC) is hosting the 3rd edition of its PSCC Innovation Forum in Villejuif. More than 700 oncology stakeholders -researchers, clinicians, start-ups, industrial players, investors, and patient representatives - are gathering around a shared conviction: t he future of oncology now lies in the ability to rapidly translate scientific innovation into tangible clinical impact. Each year, nearly 4
Feb 4
(In French) Hack4Hope 2025 : Ensemble pour transformer la prise en charge des cancers pédiatriques
Une deuxième édition ambitieuse dédiée aux cancers de l’enfant et de l’adolescent , organisée par le PSCC et son Childhood Cancer Working Group, avec le soutien de LifeArc, Foundation S, Imagine for Margo, Sanofi et Bristol Myers Squibb. 9 projets finalistes sélectionnés parmi 24 candidatures, couvrant thérapies innovantes, IA, diagnostics, nanomédecine et soutien aux familles. 4 gagnants distingués par le jury : Kindling Bio (1er Prix), MSInsight (2e Prix), Hippoxis (3e Pr
Dec 5, 2025
(In French) À The Hive, le Central Lab et l’Innovation Center dévoilent leur offre aux sociétés innovantes en oncologie du PSCC
Premier événement scientifique organisé au sein de The Hive , bâtiment totem du biocluster, au cœur du Campus Grand Parc Lancement du Central Lab , bientôt opérationnel pour accompagner les projets précliniques et cliniques Déploiement de l’ Innovation Center , une offre modulable destinée aux jeunes start-ups Présentation de deux nouveaux locataires de The Hive : Valerio Therapeutics , et Signadori Bio Villejuif, le 04 décembre 2025 – Organisée à The Hive, bâtiment de 25
Dec 4, 2025
Cluster News
Webinar: Understanding the BPI’s French Tech Seed investment commitments to boost fundraising
Un webinar organisé par le PSCC présentant le dispositif des obligations convertibles de la BPI pour les entreprises Deeptech.
Jul 20
IA4Clinical Trials Symposium
Yesterday, more than 120 participants gathered at The Hive for the AI 4 Clinical Trials Symposium, co-organised by Future4Care and PSCC Connect. The day opened with an inspiring keynote by Stéphanie Allassonnière (Université Paris Cité), "Smarter Trials, Faster Cures: The AI Revolution in Clinical Research." Her presentation highlighted a clear message: AI is no longer a promise—it is already transforming every stage of clinical research. Throughout the morning, three e
Jul 2
Tailored Antigens, Leaner Workflows: Accelerating Therapeutic Antibody and ADC Discovery
On 23 June 2026, the Ecosystem Breakfast took place on the theme “Tailored Antigens, Leaner Workflows: Accelerating Therapeutic Antibody and ADC Discovery.” The presentations are available below. Please note that no replay is available. with: Jacques Fieschi, Chief Scientific Officer, MImAbs Thomas Vinos-Poyo, Account Manager, ACROBiosystems AG
Jun 25
New oncology innovators join the PSCC BOOST programme
This quarter, eight innovative oncology-focused projects have been selected to join the BOOST programme of the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence, and international reach of the ecosystem. From cancer vaccines and oncolytic viruses to precision immunotherapies, ADC technologies, photodynamic therapies, and innovative diagnostics, these projects illustrate the breadth of approaches supported by PSCC to accelerate the
Jun 22
Cluster News
New oncology innovators join the PSCC BOOST programme
This quarter, eight innovative oncology-focused projects have been selected to join the BOOST programme of the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence, and international reach of the ecosystem. From cancer vaccines and oncolytic viruses to precision immunotherapies, ADC technologies, photodynamic therapies, and innovative diagnostics, these projects illustrate the breadth of approaches supported by PSCC to accelerate the
Jun 22
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
New start-ups join the PSCC BOOST programme
For the beginning of 2026, five innovative oncology-focused projects were successful in the selection process and join the BOOST programme of the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From novel therapeutic modalities to next-generation biologics , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of breakthrough science into tangible imp
Jan 7
9 new projects supported by the PSCC
From diagnosis to therapies, from molecules to algorithms: innovation takes multiple forms within the Paris Saclay Cancer Cluster (PSCC)....
Sep 25, 2025
Cluster News
Les Echos - A Villejuif, le cluster de l'oncologie prend de l'ampleur (in french)
Huit entreprises, 250 salariés et un fonds de subvention de 2,5 millions d'euros… Le Paris-Saclay Cancer Cluster met les bouchées doubles à Villejuif pour accélérer le passage de la recherche à la fabrication de traitement contre le cancer. Le Paris-Saclay Cancer Cluster met les bouchées doubles. Ce cluster, financé par l'Etat à hauteur de 100 millions d'euros, développe un pôle consacré à l'oncologie et à la déclinaison de la recherche en traitement pour trouver des solution
Feb 6
Mind Health - Le PSCC dévoile ses ambitions pour 2026 (in French)
Le Paris-Saclay Cancer Cluster (PSCC), le biocluster dédié à l'oncologie, a présenté le 4 février un bilan de son activité depuis sa création en 2022 à l'occasion du PSCC Innovation Forum 2026. Son Campus, doté d'un investissement de 1,8 Mds €, sort progressivement de terre : 45 000 m² de laboratoires et de bureaux sont opérationnels depuis 2025. En janvier, sept entreprises, dont Sanofi et One Biosciences, ont déjà rejoint le cluster et le PSCC vise l'installation de plus de
Feb 6
L'Express - Visite exclusive au cœur du "Paris-Saclay Cancer Cluster" : "Grâce à cet incubateur, tout va plus vite (in french)
Reportage. Sous l’impulsion d’Emmanuel Macron, la France tente d’ériger à Villejuif un incubateur géant pour aider les scientifiques à transformer leurs idées en médicaments. C'est vrai que l'on s’y perd dans ces couloirs où rien n’est indiqué, au milieu de toutes ces salles nues, qui attendent encore qu’on les habille de meubles et de moquettes. Le "Paris-Saclay Cancer Cluster", projet d’incubateur inédit en France, n’est pas tout à fait fini, et cela se devine à tous ces sa
Feb 3
L'Express - Cancer, les vrais progrès de la science : "La frontière de la guérison a bougé"
Sciences et santé. Les médecins arrivent désormais à prolonger la vie de certains patients atteints de tumeurs métastatiques. Une révolution, même si le cancer reste la première cause de décès dans notre pays. On dit de Valérie, 56 ans, qu’elle a "bonne mine". Qu’elle n’a pas l’air "malade". Peut-être est-ce dû à cet infatigable entrain, elle qui a toujours eu une énergie "débordante" et mille projets à la fois, cadre dans l’assurance et élue d’une petite commune du sud de la
Nov 26, 2025
Cluster News
Webinar: Understanding the BPI’s French Tech Seed investment commitments to boost fundraising
Un webinar organisé par le PSCC présentant le dispositif des obligations convertibles de la BPI pour les entreprises Deeptech.
Jul 20
IA4Clinical Trials Symposium
Yesterday, more than 120 participants gathered at The Hive for the AI 4 Clinical Trials Symposium, co-organised by Future4Care and PSCC Connect. The day opened with an inspiring keynote by Stéphanie Allassonnière (Université Paris Cité), "Smarter Trials, Faster Cures: The AI Revolution in Clinical Research." Her presentation highlighted a clear message: AI is no longer a promise—it is already transforming every stage of clinical research. Throughout the morning, three e
Jul 2
Tailored Antigens, Leaner Workflows: Accelerating Therapeutic Antibody and ADC Discovery
On 23 June 2026, the Ecosystem Breakfast took place on the theme “Tailored Antigens, Leaner Workflows: Accelerating Therapeutic Antibody and ADC Discovery.” The presentations are available below. Please note that no replay is available. with: Jacques Fieschi, Chief Scientific Officer, MImAbs Thomas Vinos-Poyo, Account Manager, ACROBiosystems AG
Jun 25
New oncology innovators join the PSCC BOOST programme
This quarter, eight innovative oncology-focused projects have been selected to join the BOOST programme of the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence, and international reach of the ecosystem. From cancer vaccines and oncolytic viruses to precision immunotherapies, ADC technologies, photodynamic therapies, and innovative diagnostics, these projects illustrate the breadth of approaches supported by PSCC to accelerate the
Jun 22
bottom of page